A prospective study of snakebite in a tertiary care hospital in south-western Nepal

Author:

Pandey Deb Prasad123ORCID,Shrestha Bhola Ram4,Acharya Krishna Prasad5,Shah Khagendra Jang5,Thapa-Magar Chhabilal6,Dhakal Ishwari Prasad3,Mohamed Fahim1,Isbister Geoffrey K12

Affiliation:

1. South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya , Peradeniya , 20400, Sri Lanka

2. Clinical Toxicology Research Group, University of Newcastle , Newcastle, New South Wales , 2308, Australia

3. Department of Veterinary Microbiology and Parasitology, Agriculture and Forestry University , Rampur, Chitwan, Bagmati , 44200, Nepal

4. Karnali Academy of Health Sciences , Jumla, Karnali , 21200, Nepal

5. Bheri Hospital , Nepalgunj, Lumbini , 21900, Nepal

6. Kaligandaki Health Foundation , Kawasoti, Gandaki , 33016, Nepal

Abstract

Abstract Background Snakebite is a neglected public health issue in Nepal. We aimed to characterize patients with snake envenoming admitted to hospital in south-western Nepal. Methods This was a prospective cohort study of 476 snakebite patients admitted to Bheri Hospital from May to December 2017. Data were collected on patient demographics, bite circumstances, snake type, treatment-seeking behavior, clinical effects, complications and treatment. Results There were 139/476 (29%) patients with clinical features of envenomation and 10 deaths (8%), of which six were prehospital deaths; 325/476 (68%) patients used non-recommended prehospital first aid, including 278 (58%) who applied a tourniquet and 43 (9%) consulting traditional healers. Median time to hospital arrival was 1.5 (IQR: 0.8–4) h. Also, 127 envenomated patients (91%) developed neurotoxicity and 12 (9%) hemotoxicity, while 124 patients (89%) received antivenom, with a median dose of 10 (4–30) vials. Three patients developed anaphylaxis following antivenom administration; 111 of 139 (80%) cases were admitted to the ICU and 48 (35%) were intubated. Median length of hospital stay for all cases was 0.5 (IQR: 0.5–1.2) d, but it was 2.2 (IQR: 1.5–3.8) d for envenomated cases. Conclusions The majority of snakebite patients used non-recommended first aid or attended traditional healers. Almost one-third of patients developed systemic envenomation and required antivenom. The case fatality rate was high, but many died prior to arriving in hospital.

Funder

National Health and Medical Research Council

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Parasitology

Reference25 articles.

1. Snakebite envenomation turns again into a neglected tropical disease!;Chippaux;J Venom Anim Toxins Incl Trop Dis,2017

2. Snakebite envenoming;Gutiérrez;Nat Rev Dis Primers,2017

3. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths;Kasturiratne;PLoS Med,2008

4. Snakebite and its socio-economic impact on the rural population of Tamil Nadu.;Vaiyapuri;PLoS ONE,2013

5. Snakebite envenoming - a strategy for prevention and control - executive summary;World Health Organization,2019

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3